Copeptin (C-terminal provasopressin), MR-proADM (midregional proadrenomedullin), and MR-proANP (midregional proatrial natriuretic peptide) are complementary prognostic markers for CV death and HF in patients. The gene discussed is NR3C2; the disease is hydrops fetalis.